Tohoku University Technology: Cartilage Proliferation Inducer: T20-1259
Cartilage Growth × Anti-inflammation × Antioxidation: A New Approach to Preventing and Treating Joint Diseases
Cartilage loss from aging-related joint degeneration or from diseases such as temporomandibular disorder (TMD) is currently treated with anti-inflammatory drugs or artificial joint replacement, but neither can restore cartilage tissue that has already been lost. This invention relates to the chondrogenesis-promoting effect of MPMBP, a type of bisphosphonate (BP). As shown in the figure on the right, toluidine blue staining of the mandibular condyle of ovariectomized (OVX) rats, a model of estrogen-deficiency osteoporosis, showed that MPMBP administration increased the thickness of the cartilage layer (chondrocyte + hypertrophic chondrocyte layers) reduced by OVX. The newly formed cartilage was rich in proteoglycan, restoring the proteoglycan content lowered by osteoporosis to normal levels. The number of osteoclasts in the subchondral bone layer was also decreased (data not shown).
- Company:Tohoku Techno Arch Co., Ltd.
- Price:Other